Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
ABSTRACT Concern continues about whether the measurement of apolipoprotein B (apoB) is adequately standardized, and therefore, whether apoB should be applied widely in clinical care. This concern is misplaced. Our objective is to explain why and what the term “standardization” means. To produce clin...
Main Authors: | John H. Contois, Michel R. Langlois, Christa Cobbaert, Allan D. Sniderman |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.123.030405 |
Similar Items
-
Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol
by: Liliana Fonseca, et al.
Published: (2020-06-01) -
Methods on LDL particle isolation, characterization, and component fractionation for the development of novel specific oxidized LDL status markers for atherosclerotic disease risk assessment
by: Polyxeni Papadea, et al.
Published: (2023-01-01) -
Non-invasive skin cholesterol testing: a potential proxy for LDL-C and apoB serum measurements
by: Jiacheng Lai, et al.
Published: (2021-10-01) -
Postprandial decrease in LDL-cholesterol in men
with metabolic syndrome
by: Skoczyńska Anna, et al.
Published: (2015-02-01) -
An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis
by: Rosanne M. Crooke, et al.
Published: (2005-05-01)